HomeCompareINZY vs QYLD

INZY vs QYLD: Dividend Comparison 2026

INZY yields 50.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 INZY wins by $368.6K in total portfolio value
10 years
INZY
INZY
● Live price
50.00%
Share price
$4.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$394.0K
Annual income
$79,849.97
Full INZY calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — INZY vs QYLD

📍 INZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINZYQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INZY + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
INZY pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INZY
Annual income on $10K today (after 15% tax)
$4,250.00/yr
After 10yr DRIP, annual income (after tax)
$67,872.47/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, INZY beats the other by $63,062.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INZY + QYLD for your $10,000?

INZY: 50%QYLD: 50%
100% QYLD50/50100% INZY
Portfolio after 10yr
$209.7K
Annual income
$42,754.64/yr
Blended yield
20.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on INZY right now

INZY
Analyst Ratings
6
Buy
3
Hold
Consensus: Buy
Price Target
$12.00
+200.0% upside vs current
Range: $4.00 — $16.00
Altman Z
-6.5
Piotroski
2/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INZY buys
0
QYLD buys
0
No recent congressional trades found for INZY or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINZYQYLD
Forward yield50.00%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$394.0K$25.4K
Annual income after 10y$79,849.97$5,659.31
Total dividends collected$314.4K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: INZY vs QYLD ($10,000, DRIP)

YearINZY PortfolioINZY Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$15,700$5,000.00$10,352$1,192.36+$5.3KINZY
2$24,135$7,336.45$10,830$1,347.57+$13.3KINZY
3$36,365$10,540.42$11,460$1,539.07+$24.9KINZY
4$53,753$14,842.48$12,275$1,777.84+$41.5KINZY
5$78,020$20,504.11$13,323$2,078.95+$64.7KINZY
6$111,295$27,813.68$14,667$2,463.34+$96.6KINZY
7$156,166$37,080.39$16,396$2,960.57+$139.8KINZY
8$215,724$48,626.29$18,631$3,612.97+$197.1KINZY
9$293,602$62,776.77$21,548$4,482.15+$272.1KINZY
10$394,004$79,849.97$25,398$5,659.31+$368.6KINZY

INZY vs QYLD: Complete Analysis 2026

INZYStock

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Full INZY Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this INZY vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INZY vs SCHDINZY vs JEPIINZY vs OINZY vs KOINZY vs MAININZY vs XYLDINZY vs JEPQINZY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.